- Condition: Pulmonary Hypertension
Interventions: Drug: iloprost nebuliser solution; Drug: distilled water
Sponsors: Shanghai Jiao Tong University School of Medicine; Shanghai Jiao Tong University School of Medicine; Cardiothoracic Surgical Group of Chinese Society of Pediatric Surgery
Not yet recruiting - verified May 2012 - Condition: Heterotaxy Syndrome
Intervention:
Sponsors: University of Alberta; University of Alberta
Recruiting - verified May 2012 - Condition: Hypoplastic Left Heart Syndrome
Intervention:
Sponsors: Medical College of Wisconsin; Medical College of Wisconsin; Children's Hospital and Health System Foundation, Wisconsin; National Heart, Lung, and Blood Institute (NHLBI); Pediatric Heart Network
Not yet recruiting - verified April 2012 - Conditions: Congenital Heart Disease; Disorder of Fetus or Newborn
Interventions: Drug: Methylprednisolone; Drug: Placebo
Sponsors: Medical University of South Carolina; Medical University of South Carolina; National Heart, Lung, and Blood Institute (NHLBI); National Institutes of Health (NIH)
Not yet recruiting - verified April 2012 - Condition: Congenital Heart Disease
Intervention: Drug: Sildenafil
Sponsors: Universitaire Ziekenhuizen Leuven; Universitaire Ziekenhuizen Leuven
Not yet recruiting - verified March 2012 - Condition: Pancreatic Masses
Interventions: Procedure: EUS-FNA; Device: EUS-FNA with suction; Device: EUS-FNA without suction
Sponsors: Asan Medical Center; Asan Medical Center
Recruiting - verified April 2012 - Condition: Congenital Heart Defects
Intervention:
Sponsors: Medical College of Wisconsin; Medical College of Wisconsin; Children's Hospital and Health System Foundation, Wisconsin
Recruiting - verified March 2012 - Condition: Heart Disease Congenital Complex
Interventions: Drug: Hydrocortisone; Drug: Normal Saline
Sponsors: University of Alabama at Birmingham; University of Alabama at Birmingham
Recruiting - verified May 2012 - Conditions: Carney Complex; Gastrointestinal Stromal Tumor; Paraganglioma; Sarcoma
Interventions: Drug: linsitinib; Genetic: nucleic acid sequencing; Genetic: reverse transcriptase-polymerase chain reaction; Genetic: western blotting; Other: enzyme-linked immunosorbent assay; Other: immunohistochemistry staining method; Other: laboratory biomarker analysis; Other: pharmacological study; Procedure: positron emission tomography; Radiation: fludeoxyglucose F 18
Sponsors: National Cancer Institute (NCI); Sarcoma Alliance for Research through Collaboration; National Cancer Institute (NCI)
Recruiting - verified April 2012 - Conditions: Heart Defects, Congenital; Surgery
Interventions: Device: NivNava; Device: Cpap
Sponsors: Cliniques universitaires Saint-Luc- Université Catholique de Louvain; Cliniques universitaires Saint-Luc- Université Catholique de Louvain
Recruiting - verified April 2012 - Condition: Cardiomegaly
Intervention: Drug: MEK162
Sponsors: Novartis; Novartis Pharmaceuticals
Recruiting - verified March 2012 - Conditions: Congenital Heart Disease; Pulmonary Arterial Hypertension
Intervention: Drug: Sildenafil singly or in association with Bosentan
Sponsors: University of Sao Paulo General Hospital; University of Sao Paulo General Hospital; Instituto do Coracao; Fundação de Amparo à Pesquisa do Estado de São Paulo
Recruiting - verified March 2012 - Condition: Patent Foramen Ovale
Intervention: Device: PFO device closure
Sponsors: CardioVascular Research Foundation, Korea; Duk-Woo Park
Recruiting - verified March 2012 - Conditions: Diseases of Mitral Valve; Aortic Valve Disorder; Atrial Septal Defects; Intracardiac Myxoma
Interventions: Drug: Articaine hydrochloride 2% solution; Drug: Sodium Chloride
Sponsors: Helsinki University Central Hospital; Helsinki University Central Hospital
Recruiting - verified April 2012 - Condition: Patent Ductus Arteriosus
Interventions: Drug: Oral paracetamol; Drug: Oral ibuprofen
Sponsors: Zekai Tahir Burak Maternity and Teaching Hospital; Zekai Tahir Burak Maternity and Teaching Hospital
Recruiting - verified February 2012 - Condition: Patent Ductus Arteriosus
Interventions: Drug: Oral paracetamol; Drug: Oral ibuprofen
Sponsors: Zekai Tahir Burak Maternity and Teaching Hospital; Zekai Tahir Burak Maternity and Teaching Hospital
Recruiting - verified February 2012 - Condition: Alagille Syndrome
Intervention:
Sponsors: Stanford University; Stanford University
Recruiting - verified January 2012 - Conditions: Congenital Heart Disease; Cardiac Catheterization
Interventions: Drug: saline with propofol; Drug: ketamine with propofol; Drug: ketamine with propofol
Sponsors: Ibaraki Children's Hospital; Ibaraki Children's Hospital
Recruiting - verified January 2012 - Condition: Patent Ductus Arteriosus
Intervention:
Sponsors: Albany Medical College; Albany Medical College; Alere, Inc.
Recruiting - verified December 2011 - Conditions: Coronary Artery Disease; Myocardial Perfusion Abnormalities
Intervention: Drug: Regadenoson; Optison
Sponsors: University of Nebraska; Thomas R. Porter, MD; Astellas Pharma US, Inc.; GE Healthcare
Not yet recruiting - verified December 2011 - Conditions: Bundle-Branch Block; Heart Septal Defects, Ventricular
Interventions: Procedure: Echocardiography at rest; Procedure: Echocardiography during exercise; Procedure: MRI at rest; Procedure: Exercise testing
Sponsors: University of Aarhus; University of Aarhus; Aarhus University Hospital
Recruiting - verified November 2011 - Conditions: Impaired Oxygen Delivery; Congenital Heart Disease
Interventions: Other: Red blood cell transfusion; Other: Red blood cell transfusion
Sponsors: University of Rochester; University of Rochester
Not yet recruiting - verified November 2011 - Condition: Myocardial Infarction
Intervention:
Sponsors: Interventional Cardiology Research; Interventional Cardiology Research; University of British Columbia
Not yet recruiting - verified December 2011 - Condition: Patent Ductus Arteriosus
Intervention: Device: Occlutech PDA occluder
Sponsors: Occlutech International AB; Occlutech International AB
Recruiting - verified December 2011 - Condition: Heart Defects, Congenital
Intervention: Behavioral: Structured exercise training
Sponsors: University Hospital, Basel, Switzerland; University Hospital, Basel, Switzerland
Recruiting - verified October 2011 - Condition: Conotruncal Cardiac Defects
Intervention: Biological: Bood sampling for biochemicals and genetic analysis
Sponsors: Central Hospital, Nancy, France; Central Hospital, Nancy, France; Centre Hospitalier Universitaire de Besancon; University Hospital, Strasbourg, France; Centre Hospitalier Universitaire Dijon; CHU de Reims
Recruiting - verified October 2011 - Conditions: Left Ventricular Noncompaction; Isolated Noncompaction of the Ventricular Myocardium
Intervention:
Sponsors: University of Zurich; University of Zurich
Recruiting - verified November 2011 - Condition: Congenital Heart Diseases
Interventions: Drug: Sevoflurane; Other: Control
Sponsors: Xijing Hospital; Xijing Hospital
Recruiting - verified November 2011 - Conditions: Congenital Heart Defects; Growth Failure
Interventions: Other: Arm 1: NPO by mouth pre-operative; Other: Arm 2: Fresh Breast Milk pre-operative
Sponsors: Medical University of South Carolina; Medical University of South Carolina
Recruiting - verified November 2011 - Condition: Hypoplastic Left Heart Syndrome
Interventions: Other: Autologous Umbilical Cord Blood; Other: Autologous Umbilical Cord Blood
Sponsors: Duke University; Duke University
Recruiting - verified September 2011 - Condition: Kawasaki Disease
Intervention: Drug: Atorvastatin
Sponsors: University of California, San Diego; University of California, San Diego
Not yet recruiting - verified September 2011 - Conditions: Prematurity of Fetus; Patent Ductus Arteriosus
Interventions: Drug: Indomethacin; Procedure: Surgical Ligation
Sponsors: University of Ulm; University of Ulm
Recruiting - verified August 2011 - Conditions: Idiopathic Growth Hormone Deficiency; Turner Syndrome
Intervention: Other: Blood sampling
Sponsors: Merck KGaA; Merck KGaA; Merck Serono S.A., Geneva
Recruiting - verified May 2012 - Conditions: Obesity; Cardiovascular Abnormalities
Intervention:
Sponsors: New York University School of Medicine; New York University School of Medicine
Recruiting - verified July 2011 - Condition: Tetralogy of Fallot
Intervention: Device: Ventripoint Medical System
Sponsors: VentriPoint Diagnostics Ltd.; VentriPoint Diagnostics Ltd.
Recruiting - verified March 2012 - Condition: Cyanotic Congenital Heart Disease
Interventions: Drug: Topiramate; Other: No medication, but routine heart surgery
Sponsors: University of California, Davis; University of California, Davis
Recruiting - verified August 2011 - Condition: Heart Defects, Congenital
Intervention:
Sponsors: Oslo University Hospital; Oslo University Hospital; Haukeland University Hospital
Recruiting - verified August 2011 - Conditions: Muscular Dystrophy; Congenital Muscular Dystrophy; Fukutin-related Protein Gene; Limb Girdle; FKRP Gene; Childhood Onset LGMD; Adult Onset LGMD; POMT1; POMT2; POMGnT1; LARGE; Alpha Dystroglycan; Dystroglycanopathy; Centronuclear; Multiminicore; Multicore; Minicore; Congenital Fiber Type Disproportion; Myotubular; Nemaline; Congenital Myopathy; Neuromuscular; Rigid Spine; Phenotype-Genotype Correlation; Cough Assisted Device; Neuromuscular Disease; Respiratory Exacerbation; Invasive Ventilation; Chest Physiotherapy; Congenital Myopathies; Genetic Mutations; Hypertrophic Cardiomyopathy; Wheelchair Use; Cataract; Opthalmoplegia; Ullrich Congenital Muscular Dystrophy; Intermediate Collagen VI Myopathy; Laminin Alpha 2 Related Congenital Muscular Dystrophy; MDC1A; Merosin Deficient Congenital Muscular Dystrophy; Congenital Muscular Dystrophy Undiagnosed; Congenital Muscular Dystrophy Merosin Positive; Walker Warburg Syndrome; Muscle Eye Brain Disease; Fukuyama; Integrin Alpha 7 Deficiency; Integrin Alpha 9 Deficiency; Laminopathy; Lamin AC; SEPN 1 Related Myopathies; Bethlem Myopathy; Dystroglycanopathies; LGMD2K; LGMD2I; LGMD2L; LGMD2N; Actin Aggregation Myopathy; Cap Disease; Central Core Disease; Centronuclear Myopathy; Core Rod Myopathy; Hyaline Body Myopathy; Multiminicore Myopathy; Myotubular Myopathy; Nemaline Myopathy; Tubular Aggregate Myopathy; Zebra Body Disease Myopathy; Congenital Myopathy Other; Reducing Body Myopathy; Sarcotubular Myopathy; Spheroid Body Myopathy
Intervention:
Sponsors: Cure CMD; Cure CMD
Recruiting - verified July 2011 - Conditions: Pulmonary Arterial Hypertension; Eisenmenger Syndrome
Intervention: Other: respiratory and exercise therapy
Sponsors: University of Heidelberg; University of Heidelberg
Recruiting - verified March 2012 - Condition: Oral Ibuprofen Prophylaxis in Very Low Birth Weight Infants
Interventions: Drug: ibuprofen; Drug: ibuprofen
Sponsors: Zekai Tahir Burak Maternity and Teaching Hospital; Zekai Tahir Burak Maternity and Teaching Hospital
Recruiting - verified July 2011 - Conditions: Blood Pressure; Heart Rate and Rhythm Disorders; Hypoglycemia; Lactate; Nitrate; Cholesterol (Total and HDL); Abnormality in Fetal Heart Rate or Rhythm, Unspecified as to Episode of Care
Intervention: Other: Physical exercise
Sponsors: Instituto Materno Infantil Prof. Fernando Figueira; Instituto Materno Infantil Prof. Fernando Figueira; Professor Fernando Figueira Integral Medicine Institute; Federal University of Paraíba
Not yet recruiting - verified June 2011 - Conditions: Foramen Ovale, Patent; Heart Defects, Congenital; Heart Septal Defects
Intervention: Device: Transcatheter PFO closure with the SeptRx Intrapocket PFO Occluder (IPO)
Sponsors: SeptRx, Inc.; SeptRx, Inc.
Recruiting - verified June 2011 - Condition: Congenital Heart Defects
Intervention: Procedure: Percutaneous pulmonary valve implantation or open heart surgery
Sponsors: Oslo University Hospital; Oslo University Hospital
Not yet recruiting - verified August 2011 - Conditions: Turner Syndrome; Ovarian Insufficiency
Intervention: Procedure: Ovariectomy
Sponsors: Assistance Publique - Hôpitaux de Paris; Assistance Publique - Hôpitaux de Paris; Groupe Hospitalier Pitie-Salpetriere; Cochin Hospital
Recruiting - verified July 2011 - Conditions: Chronic Kidney Disease; Renal Osteodystrophy; Left Ventricular Hypertrophy
Intervention:
Sponsors: RFM Renal Treatment Services; RFM Renal Treatment Services
Not yet recruiting - verified June 2011 - Conditions: Coronary Artery Disease; Proteus Syndrome; Coffin - Sins Syndrome; Familial Isolated Hyperparathyroidism; Dubouitz Syndrome
Intervention:
Sponsors: National Institutes of Health Clinical Center (CC); National Human Genome Research Institute (NHGRI)
Recruiting - verified March 2012 - Condition: Turner Syndrome
Intervention: Drug: somatotropin
Sponsors: University of North Carolina, Chapel Hill; Marsha Davenport, MD; Pfizer
Recruiting - verified January 2012 - Conditions: Ehlers Danlos Syndrome; External Hydrocephalus; Dysautonomia; Postural Orthostatic Tachycardia Syndrome; Venous Insufficiency
Intervention:
Sponsors: Genetic Disease Investigators; Genetic Disease Investigators
Recruiting - verified June 2011 - Conditions: Congenital Heart Defect; Surgery-Induced Tissue Adhesions; Hemorrhage
Intervention: Device: CoSeal Surgical Spray Group
Sponsors: Loma Linda University; Loma Linda University; Baxter Healthcare Corporation
Recruiting - verified March 2012 - Condition: Patent Foramen Ovale
Intervention: Device: Cardiox FDS
Sponsors: Cardiox Corporation; Cardiox Corporation
Recruiting - verified May 2012 - Conditions: Marfan Syndrome; Turner Syndrome; Ehlers-Danlos Syndrome; Loeys-Dietz Syndrome; FBN1, TGFBR1, TGFBR2, ACTA2 or MYH11 Genetic Mutation; Bicuspid Aortic Valve Without Known Family History; Bicuspid Aortic Valve With Family History; Bicuspid Aortic Valve With Coarctation; Familial Thoracic Aortic Aneurysm and Dissections; Shprintzen-Goldberg Syndrome; Other Aneurysms and Dissections of the Thoracic Aorta Not Due to Trauma, <50yo; Other Congenital Heart Disease
Intervention:
Sponsors: National Heart, Lung, and Blood Institute (NHLBI); National Heart, Lung, and Blood Institute (NHLBI); National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Recruiting - verified May 2012 - Conditions: Pulmonary Arterial Hypertension; Congenital Heart Disease; Eisenmenger's Syndrome
Intervention: Drug: Iloprost
Sponsors: University of California, Los Angeles; University of California, Los Angeles; Actelion
Recruiting - verified June 2011 - Condition: Patent Ductus Arteriosus
Interventions: Drug: Paracetamol; Drug: NSAID; Drug: D5W
Sponsors: Shaare Zedek Medical Center; Shaare Zedek Medical Center
Not yet recruiting - verified February 2011 - Condition: Congenital Heart Defects
Interventions: Behavioral: Clinic-based Educational Intervention; Other: Usual Care
Sponsors: University of Alberta; University of Alberta; Women and Children's Health Research Institute, Canada; Stollery Children's Hospital Foundation
Recruiting - verified January 2012 - Conditions: Caridovascular Disease; Congenital Heart Disease; Pulmonary Hypertension
Interventions: Device: Balloon catheter for right heart catheterization; Drug: Gadopentate Dimeglumine (Gadolinium); Contrast Agent; Procedure: Right Heart Catheterization; Procedure: Cardiac Real-time MRI; Procedure: Vascular Hemostasis
Sponsors: National Institutes of Health Clinical Center (CC); National Heart, Lung, and Blood Institute (NHLBI)
Recruiting - verified December 2011 - Conditions: Congenital Heart Disease; Cardiopulmonary Bypass
Intervention: Drug: Acetaminophen
Sponsors: Vanderbilt University; Vanderbilt University
Recruiting - verified April 2012 - Condition: Heart Septal Defects, Atrial
Interventions: Drug: Bosentan; Drug: Placebo
Sponsors: Universitaire Ziekenhuizen Leuven; Universitaire Ziekenhuizen Leuven
Recruiting - verified October 2010 - Condition: Hypoplastic Left Heart Syndrome
Intervention: Device: Peritoneal dialysis
Sponsors: University of Alberta; University of Alberta; Women and Children's Health Research Institute, Canada
Recruiting - verified May 2012 - Conditions: Recent Stroke; Pulmonary Embolism; Patent Foramen Ovale
Intervention:
Sponsors: University Hospital, Brest; University Hospital, Brest
Recruiting - verified December 2011 - Condition: Cardiac Surgical Procedures
Intervention:
Sponsors: Weill Medical College of Cornell University; Weill Medical College of Cornell University
Recruiting - verified March 2012 - Conditions: Complete DiGeorge Anomaly; DiGeorge Syndrome; DiGeorge Anomaly; Complete DiGeorge Syndrome
Interventions: Biological: Thymus Transplantation; Procedure: Blood Draw
Sponsors: Duke University; M. Louise Markert; National Institutes of Health (NIH); National Institute of Allergy and Infectious Diseases (NIAID); Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Recruiting - verified February 2012 - Condition: Congenital Heart Defects
Intervention:
Sponsors: National Heart, Lung, and Blood Institute (NHLBI); National Heart, Lung, and Blood Institute (NHLBI)
Recruiting - verified June 2011 - Condition: Congenital Heart Disease
Intervention: Other: Blood Sample Collection
Sponsors: Nationwide Children's Hospital; Nationwide Children's Hospital
Recruiting - verified February 2012 - Condition: Congenital Heart Disease
Intervention: Drug: Bosentan
Sponsors: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA); Berto J Bouma
Recruiting - verified September 2011 - Conditions: Rheumatic Heart Disease; Congenital Heart Disease; Aneurysm; Heart Valve Disease
Intervention: Drug: Simvastatin
Sponsors: Sun Yat-sen University; Sun Yat-sen University
Recruiting - verified September 2010 - Conditions: Dyslipidemias; Hypercholesterolemia; Hypertriglyceridemia; High LDL-C; Low HDL-C
Interventions: Drug: Statin; Drug: Statin
Sponsors: Merck; Merck
Recruiting - verified May 2012 - Conditions: Pulmonary Arterial Hypertension; HIV Infection; Congenital Heart Defect; Systemic Sclerosis; Connective Tissue Disease
Interventions: Procedure: skin biopsy; Other: Blood Sample
Sponsors: Assistance Publique - Hôpitaux de Paris; Assistance Publique - Hôpitaux de Paris
Recruiting - verified August 2011 - Conditions: Stroke; Foramen Ovale, Patent
Intervention:
Sponsors: University Hospital, Geneva; University Hospital, Geneva
Recruiting - verified August 2011 - Condition: Coronary Vessel Anomalies
Intervention: Procedure: revascularization
Sponsors: Seoul National University Hospital; Seoul National University Hospital
Recruiting - verified July 2011 - Conditions: Failing Fontan Physiology; Failing Fontan; Single-ventricle; Single-ventricle Fontan; Single-ventricle Physiology
Intervention: Device: HeartMate II Ventricular Assist Device
Sponsors: Providence Health & Services; Timothy Icenogle, MD; Alexa Schmitt, PhD
Recruiting - verified March 2012 - Condition: Congenital Heart Disease
Intervention:
Sponsors: Children's Hospital of Philadelphia; Children's Hospital of Philadelphia
Recruiting - verified December 2011 - Conditions: Congenital Heart Disease; Prematurity; Necrotizing Enterocolitis
Intervention:
Sponsors: University of Utah; University of Utah
Recruiting - verified May 2012 - Condition: Williams Syndrome
Intervention:
Sponsors: National Institutes of Health Clinical Center (CC); National Institute of Mental Health (NIMH)
Recruiting - verified February 2012 - Conditions: Atrial Septal Defect; Ventricular Septal Defect; Atrioventricular Septal Defect
Interventions: Drug: Intravenous L-Citrulline; Drug: Placebo of Intravenous L-Citrulline
Sponsors: Asklepion Pharmaceuticals, LLC; Asklepion Pharmaceuticals, LLC
Recruiting - verified September 2011 - Condition: Thrombosis
Intervention: Drug: Low molecular weight heparin
Sponsors: Third Military Medical University; Third Military Medical University; Chongqing Medical University
Recruiting - verified January 2012 - Condition: Primary Ciliary Dyskinesia
Intervention:
Sponsors: Ziv Hospital; Ziv Hospital; Rambam Health Care Campus; Hadassah Medical Organization; Tel-Aviv Sourasky Medical Center; Sheba Medical Center; Assaf-Harofeh Medical Center; The Nazareth Hospital, Israel; Soroka University Medical Center; Shaare Zedek Medical Center; Schneider Children's Medical Center, Israel
Recruiting - verified May 2012 - Condition: Congenital Heart Disease
Intervention:
Sponsors: Children's Hospital Boston; Children's Hospital Boston
Recruiting - verified June 2011 - Conditions: Congenital Heart Defects; Hypoplastic Left Heart Syndrome; Aortic Coarctation
Interventions: Procedure: Deep Hypothermic Circulatory Arrest; Procedure: Antegrade Cerebral Perfusion
Sponsors: UMC Utrecht; UMC Utrecht
Recruiting - verified July 2011 - Condition: PHACE Syndrome
Intervention:
Sponsors: Medical College of Wisconsin; Medical College of Wisconsin
Recruiting - verified July 2011 - Conditions: Ischemic Brain Injury; Stroke; Healthy Individual; Patent Foramen Ovale (PFO); Neurovascular Injury
Intervention:
Sponsors: Massachusetts General Hospital; Massachusetts General Hospital; National Institute of Neurological Disorders and Stroke (NINDS)
Recruiting - verified July 2011 - Conditions: Pulmonary Hypertension; Neonatal Hypoxic Respiratory Failure; Persistent Pulmonary Hypertension of Newborn; Congenital Heart Defects; Acute Respiratory Distress Syndrome
Interventions: Drug: Iloprost; Drug: Placebo
Sponsors: Seattle Children's Hospital; Seattle Children's Hospital; Actelion
Recruiting - verified July 2011 - Condition: Double Outlet Right Ventricle
Intervention: Other: Anatomic Reconstruction and Surgical Planning
Sponsors: Emory University; Emory University
Recruiting - verified May 2011 - Condition: Neonatal Congenital Heart Disease
Intervention:
Sponsors: Emory University; Emory University; Children's Healthcare of Atlanta
Recruiting - verified March 2012 - Condition: Turner Syndrome
Intervention:
Sponsors: University of North Carolina, Chapel Hill; University of North Carolina, Chapel Hill; National Institute of Mental Health (NIMH)
Recruiting - verified December 2011 - Condition: Williams Beuren Syndrome
Interventions: Drug: Minoxidil; Drug: Placebo
Sponsors: Hospices Civils de Lyon; Hospices Civils de Lyon
Recruiting - verified July 2011 - Conditions: Stroke; Transient Ischemic Attack
Interventions: Drug: Antithrombotic treatment; Device: percutaneous device closure of PFO
Sponsors: University Hospital Inselspital, Berne; University Hospital Inselspital, Berne; University Hospital, Basel, Switzerland; University of Lausanne Hospitals; University Hospital, Geneva; University Hospital, Zürich; Triemli Hospital; Cantonal Hospital of Aarau, Switzerland; Alfried-Krupp Krankenhaus of Essen, Germany; University Hospital, Essen; Klinikum Worms gGmbH, Germany; Tufts Medical Center; Baystate Medical Center; East Medical Center Tyler, Texas; Universitaire Ziekenhuizen Leuven
Recruiting - verified January 2012 - Conditions: Angina Pectoris; Left Ventricular Wall Motion Abnormalities
Intervention: Procedure: 2D-strain echo
Sponsors: RWTH Aachen University; RWTH Aachen University
Recruiting - verified March 2012 - Condition: Pancreatic Head Mass
Intervention: Procedure: Transgastric diagnostic endoscopic peritoneoscopy
Sponsors: Ohio State University; Jeffrey Hazey; Natural Orifice Surgery Consortium for Assessment and Research
Recruiting - verified May 2012 - Condition: Kartagener Syndrome
Intervention:
Sponsors: University of North Carolina, Chapel Hill; University of North Carolina, Chapel Hill; National Heart, Lung, and Blood Institute (NHLBI)
Recruiting - verified February 2012 - Condition: Migraine
Intervention: Drug: Clopidogrel
Sponsors: Laval University; Laval University; Sanofi-Aventis; Bristol-Myers Squibb
Recruiting - verified May 2012 - Condition: Patent Ductus Arteriosus
Intervention:
Sponsors: University of Utah; University of Utah
Recruiting - verified December 2011 - Conditions: Primary Ciliary Dyskinesia; Kartagener Syndrome
Intervention: Other: Blood sample
Sponsors: Assistance Publique - Hôpitaux de Paris; Assistance Publique - Hôpitaux de Paris
Recruiting - verified August 2011 - Condition: Marfan Syndrome
Interventions: Drug: Losartan; Drug: Placebo
Sponsors: University Hospital, Ghent; University Hospital, Ghent; IWT, Belgium
Recruiting - verified March 2012 - Conditions: Congenital Abnormalities; Birth Defects; Congenital Defects
Intervention:
Sponsors: National Institutes of Health Clinical Center (CC); National Human Genome Research Institute (NHGRI)
Recruiting - verified May 2012 - Condition: Congenital Heart Disease
Intervention:
Sponsors: Emory University; Emory University
Recruiting - verified June 2011 - Condition: Marfan Syndrome
Interventions: Drug: placebo; Drug: Losartan
Sponsors: Assistance Publique - Hôpitaux de Paris; Assistance Publique - Hôpitaux de Paris
Recruiting - verified August 2008 - Conditions: Stroke; Transient Ischemic Attack
Intervention: Device: GORE HELEX™ Septal Occluder
Sponsors: W.L.Gore & Associates; W.L.Gore & Associates
Recruiting - verified September 2011 - Condition: Patent Ductus Arteriosus
Interventions: Other: feeding; Other: fasting
Sponsors: University of California, San Francisco; University of California, San Francisco
Recruiting - verified April 2012 - Condition: Congenital Heart Disease
Intervention:
Sponsors: Columbia University; Columbia University
Recruiting - verified December 2011 - Condition: Marfan Syndrome
Interventions: Drug: Losartan and nebivolol; Drug: Losartan; Drug: Nebivolol
Sponsors: IRCCS Policlinico S. Matteo; IRCCS Policlinico S. Matteo; Merck; Menarini Group
Recruiting - verified July 2011 - Conditions: Primary; Complex; Pigmented Nodular Adrenocortical Disease, Primary, 1; Periorificial Lentiginosis; Cardiac Myxoma
Intervention:
Sponsors: Assistance Publique - Hôpitaux de Paris; Assistance Publique - Hôpitaux de Paris
Recruiting - verified December 2011 - Condition: Atrial Septal Defect
Intervention: Device: AMPLATZER Septal Occluder
Sponsors: AGA Medical Corporation; AGA Medical Corporation
Recruiting - verified May 2010 - Condition: Ventricular Septal Defects
Intervention: Device: Muscular VSD Occluder device implantation (AMPLATZER Muscular VSD Occluder)
Sponsors: AGA Medical Corporation; AGA Medical Corporation
Recruiting - verified October 2009 - Conditions: Patent Foramen Ovale; Stroke
Intervention: Device: Device closure with the AMPLATZER PFO Occluder
Sponsors: AGA Medical Corporation; AGA Medical Corporation
Available - verified September 2011 - Conditions: Liver Diseases; Alagille Syndrome; Alpha 1-Antitrypsin Deficiency
Intervention:
Sponsors: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Recruiting - verified September 2011 - Condition: Congenital Heart Disease
Intervention:
Sponsors: Medical College of Wisconsin; Medical College of Wisconsin; Children's Hospital and Health System Foundation, Wisconsin
Recruiting - verified February 2012 - Condition: Heart Defects, Congenital
Interventions: Drug: nesiritide; Drug: milrinone; Drug: placebo
Sponsors: Children's Hospital Boston; Children's Hospital Boston; American Heart Association
Recruiting - verified June 2011 - Conditions: Andersen-Tawil Syndrome; Andersen Syndrome
Intervention:
Sponsors: University of Rochester; University of Rochester; Office of Rare Diseases (ORD); Rare Diseases Clinical Research Network; National Center for Research Resources (NCRR)
Recruiting - verified January 2012 - Conditions: Congenital Heart Disease; Atherosclerosis; Myocardial Ischemia; Myocardial Infarction; Acquired Heart Disease
Intervention:
Sponsors: National Institutes of Health Clinical Center (CC); National Heart, Lung, and Blood Institute (NHLBI)
Recruiting - verified January 2012 - Conditions: Turner Syndrome; Ovarian Failure, Premature; Sex Chromosome Aberrations; Menopause; Perimenopause
Intervention:
Sponsors: National Institutes of Health Clinical Center (CC); National Eye Institute (NEI)
Recruiting - verified October 2009 - Condition: Congenital Heart Defects
Intervention: Device: implantation and testing of CRT
Sponsors: Competence Network for Congenital Heart Defects; Competence Network for Congenital Heart Defects
Recruiting - verified August 2011 - Conditions: Cardiopulmonary Bypass; Heart Defects, Congenital; Hyperglycemia
Interventions: Drug: Insulin; Other: Usual Care
Sponsors: National Heart, Lung, and Blood Institute (NHLBI); National Heart, Lung, and Blood Institute (NHLBI)
Recruiting - verified July 2011 - Conditions: Migraine Headaches; Patent Foramen Ovale
Interventions: Other: Sham Procedure; Device: AMPLATZER PFO Occluder
Sponsors: AGA Medical Corporation; AGA Medical Corporation
Recruiting - verified April 2012 - Conditions: Kartagener Syndrome; Cystic Fibrosis; Pseudohypoaldosteronism; Primary Ciliary Dyskinesia
Intervention:
Sponsors: University of North Carolina, Chapel Hill; University of North Carolina, Chapel Hill; Rare Diseases Clinical Research Network; National Center for Research Resources (NCRR); NIH Office of the Director
Recruiting - verified February 2012 - Condition: Turner Syndrome
Intervention: Drug: Somatropin
Sponsors: Eli Lilly and Company; Eli Lilly and Company
Recruiting - verified April 2012 - Condition: Turner's Syndrome
Intervention:
Sponsors: National Institutes of Health Clinical Center (CC); Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Recruiting - verified February 2012 - Conditions: Cushing's Syndrome; Hereditary Neoplastic Syndrome; Lentigo; Neoplasm; Testicular Neoplasm
Intervention:
Sponsors: National Institutes of Health Clinical Center (CC); Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Recruiting - verified June 2011
 |
Join Clinical trials for Cardiac Abnormality |
